Sellas Life Sciences Stock Buy Hold or Sell Recommendation
| SLS Stock | USD 1.17 0.05 4.10% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Sellas Life Sciences is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Sellas Life Sciences given historical horizon and risk tolerance towards Sellas Life. When Macroaxis issues a 'buy' or 'sell' recommendation for Sellas Life Sciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Sellas Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Sellas and provide practical buy, sell, or hold advice based on investors' constraints. Sellas Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Sellas |
Execute Sellas Life Buy or Sell Advice
The Sellas recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Sellas Life Sciences. Macroaxis does not own or have any residual interests in Sellas Life Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Sellas Life's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Sellas Life Trading Alerts and Improvement Suggestions
| Sellas Life Sciences generated a negative expected return over the last 90 days | |
| Sellas Life Sciences may become a speculative penny stock | |
| Sellas Life Sciences has high historical volatility and very poor performance | |
| Reported Net Loss for the year was (37.34 M) with profit before taxes, overhead, and interest of 900 K. | |
| Sellas Life Sciences has about 26.99 M in cash with (31.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Sellas Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Sellas Life Sciences options imply 22.6 percent move in share price post-earnings - TipRanks |
Sellas Life Returns Distribution Density
The distribution of Sellas Life's historical returns is an attempt to chart the uncertainty of Sellas Life's future price movements. The chart of the probability distribution of Sellas Life daily returns describes the distribution of returns around its average expected value. We use Sellas Life Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Sellas Life returns is essential to provide solid investment advice for Sellas Life.
| Mean Return | -0.13 | Value At Risk | -4 | Potential Upside | 5.60 | Standard Deviation | 3.09 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Sellas Life historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Sellas Stock Institutional Investors
The Sellas Life's institutional investors refer to entities that pool money to purchase Sellas Life's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Virtu Financial Llc | 2024-06-30 | 63.8 K | Xtx Topco Ltd | 2024-09-30 | 62.8 K | Springbok Capital Management, Llc | 2024-09-30 | 58.3 K | Lpl Financial Corp | 2024-09-30 | 51.9 K | Citadel Advisors Llc | 2024-09-30 | 47.3 K | Mariner Wealth Advisors Llc | 2024-06-30 | 44.9 K | Jane Street Group Llc | 2024-06-30 | 28 K | Two Sigma Investments Llc | 2024-09-30 | 16.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 16.2 K | Vanguard Group Inc | 2024-09-30 | 2.3 M | Anson Funds Management Lp | 2024-09-30 | 793.8 K |
Sellas Life Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 1.9M | 28.0M | (13.9M) | (4.2M) | (14.6M) | (13.9M) | |
| Free Cash Flow | (17.6M) | (10.4M) | (26.0M) | (28.3M) | (36.9M) | (38.8M) | |
| Other Non Cash Items | 586K | (87K) | (4.2M) | 10.1M | 1.2M | 621.0K | |
| Net Income | (19.3M) | (16.8M) | (20.7M) | (41.3M) | (37.3M) | (39.2M) | |
| End Period Cash Flow | 7.4M | 35.4M | 21.5M | 17.2M | 2.6M | 2.5M | |
| Depreciation | 1.7M | 282K | 5.7M | 457K | 525.6K | 992.1K | |
| Change To Netincome | 3.3M | 750K | 2.3M | 11.9M | 13.6M | 14.3M |
Sellas Life Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Sellas Life or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Sellas Life's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Sellas stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.15 | |
β | Beta against Dow Jones | 0.13 | |
σ | Overall volatility | 3.12 | |
Ir | Information ratio | -0.08 |
Sellas Life Volatility Alert
Sellas Life Sciences exhibits very low volatility with skewness of 1.16 and kurtosis of 2.82. Sellas Life Sciences is a potential penny stock. Although Sellas Life may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Sellas Life Sciences. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Sellas instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Sellas Life Fundamentals Vs Peers
Comparing Sellas Life's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Sellas Life's direct or indirect competition across all of the common fundamentals between Sellas Life and the related equities. This way, we can detect undervalued stocks with similar characteristics as Sellas Life or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Sellas Life's fundamental indicators could also be used in its relative valuation, which is a method of valuing Sellas Life by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Sellas Life to competition |
| Fundamentals | Sellas Life | Peer Average |
| Return On Equity | -8.88 | -0.31 |
| Return On Asset | -1.29 | -0.14 |
| Current Valuation | 61.89 M | 16.62 B |
| Shares Outstanding | 70.38 M | 571.82 M |
| Shares Owned By Insiders | 0.24 % | 10.09 % |
| Shares Owned By Institutions | 7.36 % | 39.21 % |
| Number Of Shares Shorted | 8.61 M | 4.71 M |
| Price To Book | 5.18 X | 9.51 X |
| Price To Sales | 26.90 X | 11.42 X |
| Gross Profit | 900 K | 27.38 B |
| EBITDA | 529 K | 3.9 B |
| Net Income | (37.34 M) | 570.98 M |
| Cash And Equivalents | 26.99 M | 2.7 B |
| Cash Per Share | 1.31 X | 5.01 X |
| Total Debt | 906 K | 5.32 B |
| Debt To Equity | 0.06 % | 48.70 % |
| Current Ratio | 2.36 X | 2.16 X |
| Book Value Per Share | (0.25) X | 1.93 K |
| Cash Flow From Operations | (31.41 M) | 971.22 M |
| Short Ratio | 14.07 X | 4.00 X |
| Earnings Per Share | (0.67) X | 3.12 X |
| Target Price | 5.83 | |
| Number Of Employees | 16 | 18.84 K |
| Beta | 2.4 | -0.15 |
| Market Capitalization | 82.35 M | 19.03 B |
| Total Asset | 6.22 M | 29.47 B |
| Retained Earnings | (217.24 M) | 9.33 B |
| Working Capital | (10.56 M) | 1.48 B |
| Net Asset | 6.22 M |
Note: Acquisition by Kalin Katherine Bach of 19000 shares of Sellas Life subject to Rule 16b-3 [view details]
Sellas Life Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Sellas . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Sellas Life Buy or Sell Advice
When is the right time to buy or sell Sellas Life Sciences? Buying financial instruments such as Sellas Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Sellas Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Cap ETFs Thematic Idea Now
Small Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Small Cap ETFs theme has 167 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.